Pathology of breast cancer in women with constitutional CHEK2 mutations

被引:0
|
作者
Tomasz Huzarski
Cezary Cybulski
Wenancjusz Domagała
Jacek Gronwald
Tomasz Byrski
Marek Szwiec
Stanisław Woyke
Steven A Narod
Jan Lubiński
机构
[1] Pomeranian Medical University,The Centre for Research in Women’s Health
[2] Regional Oncology Hospital,International Hereditary Cancer Centre, Department of Genetics and Pathology
[3] University of Toronto,undefined
[4] Pomeranian Medical University,undefined
来源
关键词
breast cancer; CHEK 2; lobular carcinoma; risk factor;
D O I
暂无
中图分类号
学科分类号
摘要
The power of association studies between polymorphic genetic variants and breast cancer may be enhanced if the cancer subjects are subclassified by histologic subgroup. In this study we classified 482 unselected breast cancers from Szczecin, Poland by histology (ductal, lobular, medullary, other). All women were genotyped for three founder mutations in the CHEK2 gene (1100delC, IVS2 + 1G > A and I157T). There was no significant overall association between CHEK2 and breast cancer (OR = 1.3; p = 0.30), but among those with lobular carcinoma the association with the I157T missense mutation was very strong (OR = 6.6; p > 0.0001). This is the first report to demonstrate that different mutations of the same gene may be associated with specific histologic subtypes of cancer.
引用
收藏
页码:187 / 189
页数:2
相关论文
共 50 条
  • [31] Frequency of CHEK2 mutations in a population based, case-control study of breast cancer in young women
    Friedrichsen, DM
    Malone, KE
    Doody, DR
    Daling, JR
    Ostrander, EA
    BREAST CANCER RESEARCH, 2004, 6 (06): : R629 - R635
  • [32] The risk of gastric cancer in carriers of CHEK2 mutations
    Urszula Teodorczyk
    Cezary Cybulski
    Dominika Wokołorczyk
    Anna Jakubowska
    Teresa Starzyńska
    Małgorzata Ławniczak
    Paweł Domagała
    Katarzyna Ferenc
    Krzysztof Marlicz
    Zbigniew Banaszkiewicz
    Rafał Wiśniowski
    Steven A. Narod
    Jan Lubiński
    Familial Cancer, 2013, 12 : 473 - 478
  • [33] Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers
    Cybulski, Cezary
    Masojc, Bartlomiej
    Oszutowska, Dorota
    Jaworowska, Ewa
    Grodzki, Tomasz
    Waloszczyk, Piotr
    Serwatowski, Piotr
    Pankowski, Juliusz
    Huzarski, Tomasz
    Byrski, Tomasz
    Gorski, Bohdan
    Jakubowska, Anna
    Debniak, Tadeusz
    Wokolorczyk, Dominika
    Gronwald, Jacek
    Tarnowska, Czeslawa
    Serrano-Fernandez, Pablo
    Lubinski, Jan
    Narod, Steven A.
    CARCINOGENESIS, 2008, 29 (04) : 762 - 765
  • [34] High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
    Irene Rainville
    Shanell Hatcher
    Eric Rosenthal
    Katie Larson
    Ryan Bernhisel
    Stephanie Meek
    Heidi Gorringe
    Erin Mundt
    Susan Manley
    Breast Cancer Research and Treatment, 2020, 180 : 503 - 509
  • [35] High risk of breast cancer in women with biallelic pathogenic variants in CHEK2
    Rainville, Irene
    Hatcher, Shanell
    Rosenthal, Eric
    Larson, Katie
    Bernhisel, Ryan
    Meek, Stephanie
    Gorringe, Heidi
    Mundt, Erin
    Manley, Susan
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 503 - 509
  • [36] Frequency of CHEK2 gene mutations in breast cancer patients from Republic of Bashkortostan
    M. A. Bermisheva
    Z. R. Takhirova
    N. Bogdanova
    E. K. Khusnutdinova
    Molecular Biology, 2014, 48 : 46 - 51
  • [37] Frequency of CHEK2 gene mutations in breast cancer patients from Republic of Bashkortostan
    Bermisheva, M. A.
    Takhirova, Z. R.
    Bogdanova, N.
    Khusnutdinova, E. K.
    MOLECULAR BIOLOGY, 2014, 48 (01) : 46 - 51
  • [38] Time to check CHEK2 in families with breast cancer?
    Offit, Kenneth
    Garber, Judy Ellen
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 519 - 520
  • [39] Checking for CHEK2 Hereditary Mutations in Ukrainian Women: Lack of CHECK2 Variants Contribution to Breast Cancer Susceptibility
    Sulaieva, O.
    Kozakov, D.
    Livshun, S.
    Matvieieva, A.
    Shabalkov, R.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (SUPP 1) : S40 - S40
  • [40] Breast cancer in Slovene CHEK2 mutation carriers
    Blatnik, A.
    Strojnik, K.
    Stegel, V.
    Drago, V. Etrajcic
    Klancar, G.
    Novakovic, S.
    Krajc, M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 412 - 412